Scope of the Report
Persistence Market Research (PMR) recently published a market study on the global eye health supplements market. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities restraints, and detailed information about the eye health supplements market structure. The market study presents exclusive information about how the eye health supplements market will grow during the forecast period (2019-2029).
Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market and compound annual growth rate (CAGR) are explained in PMR's study in a comprehensive manner. Other information includes definition, drivers and opportunity analysis by region and by product type, which helps in the deep understanding of the market segment details by researchers, suppliers, manufactures, and distributors. This information can help readers understand the quantitative growth prospects of the eye health supplements market for forecast period.
The study is relevant for manufacturers, physicians, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Business researcher, shareholders, and industry experts can leverage the information and data presented in PMR's study.
The study also includes statistics as well as facts related to the macroeconomic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the eye health supplements market. Furthermore, small businesses and new entrants in the eye health supplements market too can make use of the information presented in this study, based on which, they can make appropriate business decisions in order to gain momentum in the market.
PMR's study on the eye health supplements market offers information divided into four important segments-ingredient, disease indication, form, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Key Questions Answered:
- Which regions will continue to remain the most profitable regional markets for eye health supplements market players?
- Which factors will induce a change in the demand for eye health supplements during the assessment period?
- What are the different opportunities available for emerging players in the eye health supplements market?
- How are supply-side and demand-side drivers re impacting the eye health supplements market?
- How will changing trends impact the eye health supplements market?
- How can market players capture the low-hanging opportunities in the eye health supplements market in developed regions?
- Which companies are leading the eye health supplements market?
- What are the winning strategies of stakeholders in the eye health supplements market to upscale their position in this landscape?
Research Methodology
In PMR's study, a unique research methodology is utilized to conduct extensive research on the growth of the eye health supplements market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the eye health supplements market study include statistics from government healthcare organizations, medicines journals, research journals, press release, annual reports, white papers, directories, and databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the market, and makes PMR's projections on the growth prospects of the eye health supplements market more accurate and reliable.
Table of Contents
1. Executive Summary
2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
3. Market Background
- 3.1. Macro-Economic Factors
- 3.2. Market Dynamics
- 3.2.1. Drivers
- 3.2.2. Restraints
- 3.2.3. Opportunity
- 3.2.4. Trends
4. Global Eye Health Supplements Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029
- 4.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
- 4.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis
5. Global Eye Health Supplements Market Analysis 2014-2018 and Forecast 2019-2029, by Ingredient Type
- 5.1. Introduction / Key Findings
- 5.2. Historical Market Size (US$ Mn) Analysis By Ingredient Type, 2014 - 2018
- 5.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Ingredient Type, 2019 - 2029
- 5.3.1. Lutein and Zeaxanthin
- 5.3.2. Antioxidants
- 5.3.3. Omega-3 Fatty Acids
- 5.3.4. Coenzyme Q10
- 5.3.5. Flavonoids
- 5.3.6. Astaxanthin
- 5.3.7. Alpha-Lipoic Acid
- 5.3.8. Other Ingredients
- 5.4. Market Attractiveness Analysis By Ingredient Type
6. Global Eye Health Supplements Market Analysis 2014-2018 and Forecast 2019-2029, by Disease Indication
- 6.1. Introduction / Key Findings
- 6.2. Historical Market Size (US$ Mn) Analysis By Disease Indication, 2014 - 2018
- 6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Indication, 2019 - 2029
- 6.3.1. Age-related Macular Degeneration (AMD)
- 6.3.2. Cataract
- 6.3.3. Dry Eye Syndrome
- 6.3.4. Other Indications
- 6.4. Market Attractiveness Analysis By Disease Indication
7. Global Eye Health Supplements Market Analysis 2014-2018 and Forecast 2019-2029, by Form
- 7.1. Introduction / Key Findings
- 7.2. Historical Market Size (US$ Mn) Analysis By Disease Indication, 2014 - 2018
- 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Form, 2019 - 2029
- 7.3.1. Tablet
- 7.3.2. Capsule
- 7.3.3. Others
- 7.4. Market Attractiveness Analysis By Disease Indication
8. Global Eye Health Supplements Market Analysis 2014-2018 and Forecast 2019-2029, by Region
- 8.1. Introduction
- 8.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2018
- 8.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029
- 8.3.1. North America
- 8.3.2. Latin America
- 8.3.3. Europe
- 8.3.4. Asia Pacific
- 8.3.5. MEA
- 8.4. Market Attractiveness Analysis By Region
9. North America Eye Health Supplements Market Analysis 2014-2018 and Forecast 2019-2029
- 9.1. Introduction
- 9.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
- 9.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
- 9.3.1. By Country
- 9.3.1.1. U.S.
- 9.3.1.2. Canada
- 9.3.2. By Ingredient Type
- 9.3.3. By Disease Indication
- 9.3.4. By Form
- 9.4. Market Attractiveness Analysis
- 9.4.1. By Country
- 9.4.2. By Ingredient Type
- 9.4.3. By Disease Indication
- 9.4.4. By Form
10. Latin America Eye Health Supplements Market Analysis 2014-2018 and Forecast 2019-2029
- 10.1. Introduction
- 10.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
- 10.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
- 10.3.1. By Country
- 10.3.1.1. Brazil
- 10.3.1.2. Mexico
- 10.3.1.3. Rest of Latin America
- 10.3.2. By Ingredient Type
- 10.3.3. By Disease Indication
- 10.3.4. By Form
- 10.4. Market Attractiveness Analysis
- 10.4.1. By Country
- 10.4.2. By Ingredient Type
- 10.4.3. By Disease Indication
- 10.4.4. By Form
11. Europe Eye Health Supplements Market Analysis 2014-2018 and Forecast 2019-2029
- 11.1. Introduction
- 11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
- 11.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
- 11.3.1. By Country
- 11.3.1.1. U.K.
- 11.3.1.2. France
- 11.3.1.3. Germany
- 11.3.1.4. Italy
- 11.3.1.5. Spain
- 11.3.1.6. Russia
- 11.3.1.7. Rest of Europe
- 11.3.2. By Ingredient Type
- 11.3.3. By Disease Indication
- 11.3.4. By Form
- 11.4. Market Attractiveness Analysis
- 11.4.1. By Country
- 11.4.2. By Ingredient Type
- 11.4.3. By Disease Indication
- 11.4.4. By Form
12. Asia Pacific Eye Health Supplements Market Analysis 2014-2018 and Forecast 2019-2029
- 12.1. Introduction
- 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
- 12.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
- 12.3.1. By Country
- 12.3.1.1. Japan
- 12.3.1.2. China
- 12.3.1.3. India
- 12.3.1.4. Australia and New Zealand
- 12.3.1.5. ASEAN
- 12.3.1.6. Rest of APAC
- 12.3.2. By Ingredient Type
- 12.3.3. By Disease Indication
- 12.3.4. By Form
- 12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Ingredient Type
- 12.4.3. By Disease Indication
- 12.4.4. By Form
13. MEA Eye Health Supplements Market Analysis 2014-2018 and Forecast 2019-2029
- 13.1. Introduction
- 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
- 13.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
- 13.3.1. By Country
- 13.3.1.1. GCC Countries
- 13.3.1.2. South Africa
- 13.3.1.3. North Africa
- 13.3.1.4. Rest of MEA
- 13.3.2. By Ingredient Type
- 13.3.3. By Disease Indication
- 13.3.4. By Form
- 13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Ingredient Type
- 13.4.3. By Disease Indication
- 13.4.4. By Form
14. Competition Analysis
- 14.1. Competition Dashboard
- 14.2. Competition Deep Dive
- 14.2.1. Pfizer Inc.
- 14.2.1.1. Overview
- 14.2.1.2. Ingredient Portfolio
- 14.2.1.3. Profitability by Market Segments (Drugs/Channel/Region)
- 14.2.1.4. Sales Footprint
- 14.2.1.5. Strategy Overview
- 14.2.1.5.1. Marketing Strategy
- 14.2.1.5.2. Ingredient Strategy
- 14.2.1.5.3. Channel Strategy
- 14.2.2. Novartis AG
- 14.2.2.1. Overview
- 14.2.2.2. Ingredient Portfolio
- 14.2.2.3. Profitability by Market Segments (Drugs/Channel/Region)
- 14.2.2.4. Sales Footprint
- 14.2.2.5. Strategy Overview
- 14.2.2.5.1. Marketing Strategy
- 14.2.2.5.2. Ingredient Strategy
- 14.2.2.5.3. Channel Strategy
- 14.2.3. Baush Health
- 14.2.3.1. Overview
- 14.2.3.2. Ingredient Portfolio
- 14.2.3.3. Profitability by Market Segments (Drugs/Channel/Region)
- 14.2.3.4. Sales Footprint
- 14.2.3.5. Strategy Overview
- 14.2.3.5.1. Marketing Strategy
- 14.2.3.5.2. Ingredient Strategy
- 14.2.3.5.3. Channel Strategy
- 14.2.4. Amway Corp.
- 14.2.4.1. Overview
- 14.2.4.2. Ingredient Portfolio
- 14.2.4.3. Profitability by Market Segments (Drugs/Channel/Region)
- 14.2.4.4. Sales Footprint
- 14.2.4.5. Strategy Overview
- 14.2.4.5.1. Marketing Strategy
- 14.2.4.5.2. Ingredient Strategy
- 14.2.4.5.3. Channel Strategy
- 14.2.5. Vitabiotics Ltd.
- 14.2.5.1. Overview
- 14.2.5.2. Ingredient Portfolio
- 14.2.5.3. Profitability by Market Segments (Drugs/Channel/Region)
- 14.2.5.4. Sales Footprint
- 14.2.5.5. Strategy Overview
- 14.2.5.5.1. Marketing Strategy
- 14.2.5.5.2. Ingredient Strategy
- 14.2.5.5.3. Channel Strategy
- 14.2.6. Alliance Pharma
- 14.2.6.1. Overview
- 14.2.6.2. Ingredient Portfolio
- 14.2.6.3. Profitability by Market Segments (Drugs/Channel/Region)
- 14.2.6.4. Sales Footprint
- 14.2.6.5. Strategy Overview
- 14.2.6.5.1. Marketing Strategy
- 14.2.6.5.2. Ingredient Strategy
- 14.2.6.5.3. Channel Strategy
- 14.2.7. The Nature's Bounty Co
- 14.2.7.1. Overview
- 14.2.7.2. Ingredient Portfolio
- 14.2.7.3. Profitability by Market Segments (Drugs/Channel/Region)
- 14.2.7.4. Sales Footprint
- 14.2.7.5. Strategy Overview
- 14.2.7.5.1. Marketing Strategy
- 14.2.7.5.2. Ingredient Strategy
- 14.2.7.5.3. Channel Strategy
15. Assumptions and Acronyms Used
16. Research Methodology
